You are right , they didn't run , but I think YOU not getting , They refused to permit 4 doses of leronlimab for severe /critical , which is very logical base on a half life of the drug... Dr Lalezari , Dr Yang , Dr Seethamraju asked for it .. But they such an expert..They said not needed.. I wonder why FDA refused to approve study with 4 weeks of treatment ..hmmmm .. All IMO.
Market Data 
Markets
AI
